Rakel, Kim http://orcid.org/0000-0001-8896-2746
Becker, Dennis
Bussen, Dino
Classen, Silke
Preuss, Thomas
Strauss, Tido
Zenker, Armin
Gergs, André
Funding for this research was provided by:
Bayer
Article History
Received: 6 April 2022
Accepted: 11 October 2022
First Online: 20 October 2022
Declarations
:
: Financial interests: Authors Kim Rakel, Dino Bussen, Silke Classen and Tido Strauss have received research funding from Bayer AG. Dennis Becker and Armin Zenker declare they have no financial interests. André Gergs and Thomas Preuss are employed at Bayer AG. Imidacloprid is an active ingredient in Bayer products.